View Financial HealthSANGBO 配当と自社株買い配当金 基準チェック /06SANGBO配当金を支払った記録がありません。主要情報n/a配当利回り0%バイバック利回り総株主利回り0%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新お知らせ • Apr 09SANGBO Corp. (KOSDAQ:A027580) announces an Equity Buyback for KRW 1,500 million worth of its shares.SANGBO Corp. (KOSDAQ:A027580) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,500 million worth of its shares pursuant to a contract with KB Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on October 8, 2024. As of April 7, 2024, the company had 1,992,650 shares in treasury within scope available for dividend and had 2,022 shares in treasury through other repurchase.すべての更新を表示Recent updatesNew Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 72% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩25.5b market cap, or US$16.9m).Reported Earnings • Mar 17Full year 2025 earnings released: ₩229 loss per share (vs ₩191 loss in FY 2024)Full year 2025 results: ₩229 loss per share (further deteriorated from ₩191 loss in FY 2024). Revenue: ₩50.1b (down 6.9% from FY 2024). Net loss: ₩12.9b (loss widened 19% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.お知らせ • Feb 20SANGBO Corp., Annual General Meeting, Mar 26, 2026SANGBO Corp., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea分析記事 • Jan 07The Market Lifts SANGBO Corp. (KOSDAQ:027580) Shares 26% But It Can Do MoreSANGBO Corp. ( KOSDAQ:027580 ) shareholders would be excited to see that the share price has had a great month, posting...New Risk • Jan 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Market cap is less than US$100m (₩54.4b market cap, or US$37.6m).分析記事 • Nov 03Is SANGBO (KOSDAQ:027580) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Jul 22SANGBO Corp.'s (KOSDAQ:027580) Share Price Could Signal Some RiskThere wouldn't be many who think SANGBO Corp.'s ( KOSDAQ:027580 ) price-to-sales (or "P/S") ratio of 1.1x is worth a...New Risk • May 23New major risk - Revenue and earnings growthEarnings have declined by 29% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 29% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩60.4b market cap, or US$44.0m).Reported Earnings • Mar 14Full year 2024 earnings released: ₩191 loss per share (vs ₩8.00 profit in FY 2023)Full year 2024 results: ₩191 loss per share (down from ₩8.00 profit in FY 2023). Revenue: ₩53.8b (down 19% from FY 2023). Net loss: ₩10.8b (down ₩11.3b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.お知らせ • Feb 12SANGBO Corp., Annual General Meeting, Mar 26, 2025SANGBO Corp., Annual General Meeting, Mar 26, 2025, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea分析記事 • Dec 14SANGBO Corp. (KOSDAQ:027580) Stock Rockets 27% As Investors Are Less Pessimistic Than ExpectedSANGBO Corp. ( KOSDAQ:027580 ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...New Risk • Dec 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩63.6b market cap, or US$44.4m).New Risk • Dec 07New minor risk - Financial data availabilityLess than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (₩72.5b market cap, or US$51.0m).分析記事 • Nov 12Is SANGBO (KOSDAQ:027580) Using Debt Sensibly?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩31.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩22.00 (down from ₩31.00 in 2Q 2023). Revenue: ₩15.5b (down 10% from 2Q 2023). Net income: ₩1.24b (down 31% from 2Q 2023). Profit margin: 8.0% (down from 10% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Buy Or Sell Opportunity • May 17Now 23% overvaluedOver the last 90 days, the stock has fallen 11% to ₩1,868. The fair value is estimated to be ₩1,524, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.Buy Or Sell Opportunity • Apr 27Now 20% overvaluedThe stock has been flat over the last 90 days, currently trading at ₩1,840. The fair value is estimated to be ₩1,532, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.お知らせ • Apr 09SANGBO Corp. (KOSDAQ:A027580) announces an Equity Buyback for KRW 1,500 million worth of its shares.SANGBO Corp. (KOSDAQ:A027580) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,500 million worth of its shares pursuant to a contract with KB Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on October 8, 2024. As of April 7, 2024, the company had 1,992,650 shares in treasury within scope available for dividend and had 2,022 shares in treasury through other repurchase.Reported Earnings • Mar 19Full year 2023 earnings released: EPS: ₩8.00 (vs ₩67.43 in FY 2022)Full year 2023 results: EPS: ₩8.00 (down from ₩67.43 in FY 2022). Revenue: ₩66.2b (down 1.9% from FY 2022). Net income: ₩438.5m (down 89% from FY 2022). Profit margin: 0.7% (down from 5.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.New Risk • Feb 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₩112.9b market cap, or US$84.7m).Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩59.03 in 3Q 2022)Third quarter 2023 results: EPS: ₩44.00 (down from ₩59.03 in 3Q 2022). Revenue: ₩17.4b (up 12% from 3Q 2022). Net income: ₩2.53b (down 26% from 3Q 2022). Profit margin: 15% (down from 22% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 23Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 30% over the past three years.Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.New Risk • Jun 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.0% net profit margin).Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₩1,966, the stock trades at a trailing P/E ratio of 59.3x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 99% over the past three years.Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩1,614, the stock trades at a trailing P/E ratio of 23.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 134% over the past three years.Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩67.43 (vs ₩82.02 in FY 2021)Full year 2022 results: EPS: ₩67.43 (down from ₩82.02 in FY 2021). Revenue: ₩67.4b (down 6.9% from FY 2021). Net income: ₩4.00b (down 1.6% from FY 2021). Profit margin: 5.9% (up from 5.6% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩1,420, the stock trades at a trailing P/E ratio of 34.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 1.3% over the past three years.Buying Opportunity • Mar 07Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be ₩2,210, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 34% per annum over the last 3 years. The company has become profitable over the last 3 years.Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS ₩60.00 (vs ₩17.00 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩33.0b (down 16% from 3Q 2020). Net income: ₩3.01b (up 282% from 3Q 2020). Profit margin: 9.1% (up from 2.0% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 23Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₩2,665, the stock trades at a trailing P/E ratio of 30.8x. Average trailing P/E is 21x in the Chemicals industry in South Korea. Total returns to shareholders of 47% over the past three years.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩1,955, the stock trades at a trailing P/E ratio of 22.7x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 5.0% over the past three years.Reported Earnings • May 16First quarter 2021 earnings released: EPS ₩18.00 (vs ₩3.00 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩34.0b (up 17% from 1Q 2020). Net income: ₩851.5m (up ₩969.3m from 1Q 2020). Profit margin: 2.5% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.分析記事 • Apr 14Returns At SANGBO (KOSDAQ:027580) Are On The Way UpThere are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...分析記事 • Mar 19SANGBO (KOSDAQ:027580) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...お知らせ • Feb 22SANGBO Corp., Annual General Meeting, Mar 24, 2021SANGBO Corp., Annual General Meeting, Mar 24, 2021, at 09:00 Korea Standard Time.Is New 90 Day High Low • Feb 08New 90-day high: ₩1,530The company is up 18% from its price of ₩1,300 on 10 November 2020. The South Korean market is up 25% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.分析記事 • Dec 09SANGBO (KOSDAQ:027580) Takes On Some Risk With Its Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Is New 90 Day High Low • Dec 01New 90-day high: ₩1,490The company is up 3.0% from its price of ₩1,445 on 02 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.Reported Earnings • Nov 13Third quarter 2020 earnings released: ₩4.17 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩15.5b (up 12% from 3Q 2019). Net loss: ₩198.9m (loss narrowed 91% from 3Q 2019). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.決済の安定と成長配当データの取得安定した配当: A027580の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: A027580の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場SANGBO 配当利回り対市場A027580 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (A027580)n/a市場下位25% (KR)1.0%市場トップ25% (KR)3.8%業界平均 (Chemicals)1.3%アナリスト予想 (A027580) (最長3年)n/a注目すべき配当: A027580は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: A027580は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: A027580の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: A027580が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YKR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 10:38終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋SANGBO Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Jeong LeeEugene Investment & Securities Co Ltd.
お知らせ • Apr 09SANGBO Corp. (KOSDAQ:A027580) announces an Equity Buyback for KRW 1,500 million worth of its shares.SANGBO Corp. (KOSDAQ:A027580) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,500 million worth of its shares pursuant to a contract with KB Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on October 8, 2024. As of April 7, 2024, the company had 1,992,650 shares in treasury within scope available for dividend and had 2,022 shares in treasury through other repurchase.
New Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 72% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩25.5b market cap, or US$16.9m).
Reported Earnings • Mar 17Full year 2025 earnings released: ₩229 loss per share (vs ₩191 loss in FY 2024)Full year 2025 results: ₩229 loss per share (further deteriorated from ₩191 loss in FY 2024). Revenue: ₩50.1b (down 6.9% from FY 2024). Net loss: ₩12.9b (loss widened 19% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 20SANGBO Corp., Annual General Meeting, Mar 26, 2026SANGBO Corp., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea
分析記事 • Jan 07The Market Lifts SANGBO Corp. (KOSDAQ:027580) Shares 26% But It Can Do MoreSANGBO Corp. ( KOSDAQ:027580 ) shareholders would be excited to see that the share price has had a great month, posting...
New Risk • Jan 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Market cap is less than US$100m (₩54.4b market cap, or US$37.6m).
分析記事 • Nov 03Is SANGBO (KOSDAQ:027580) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 • Jul 22SANGBO Corp.'s (KOSDAQ:027580) Share Price Could Signal Some RiskThere wouldn't be many who think SANGBO Corp.'s ( KOSDAQ:027580 ) price-to-sales (or "P/S") ratio of 1.1x is worth a...
New Risk • May 23New major risk - Revenue and earnings growthEarnings have declined by 29% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 29% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩60.4b market cap, or US$44.0m).
Reported Earnings • Mar 14Full year 2024 earnings released: ₩191 loss per share (vs ₩8.00 profit in FY 2023)Full year 2024 results: ₩191 loss per share (down from ₩8.00 profit in FY 2023). Revenue: ₩53.8b (down 19% from FY 2023). Net loss: ₩10.8b (down ₩11.3b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 12SANGBO Corp., Annual General Meeting, Mar 26, 2025SANGBO Corp., Annual General Meeting, Mar 26, 2025, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea
分析記事 • Dec 14SANGBO Corp. (KOSDAQ:027580) Stock Rockets 27% As Investors Are Less Pessimistic Than ExpectedSANGBO Corp. ( KOSDAQ:027580 ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...
New Risk • Dec 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩63.6b market cap, or US$44.4m).
New Risk • Dec 07New minor risk - Financial data availabilityLess than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (₩72.5b market cap, or US$51.0m).
分析記事 • Nov 12Is SANGBO (KOSDAQ:027580) Using Debt Sensibly?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩31.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩22.00 (down from ₩31.00 in 2Q 2023). Revenue: ₩15.5b (down 10% from 2Q 2023). Net income: ₩1.24b (down 31% from 2Q 2023). Profit margin: 8.0% (down from 10% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Buy Or Sell Opportunity • May 17Now 23% overvaluedOver the last 90 days, the stock has fallen 11% to ₩1,868. The fair value is estimated to be ₩1,524, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.
Buy Or Sell Opportunity • Apr 27Now 20% overvaluedThe stock has been flat over the last 90 days, currently trading at ₩1,840. The fair value is estimated to be ₩1,532, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.
お知らせ • Apr 09SANGBO Corp. (KOSDAQ:A027580) announces an Equity Buyback for KRW 1,500 million worth of its shares.SANGBO Corp. (KOSDAQ:A027580) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,500 million worth of its shares pursuant to a contract with KB Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on October 8, 2024. As of April 7, 2024, the company had 1,992,650 shares in treasury within scope available for dividend and had 2,022 shares in treasury through other repurchase.
Reported Earnings • Mar 19Full year 2023 earnings released: EPS: ₩8.00 (vs ₩67.43 in FY 2022)Full year 2023 results: EPS: ₩8.00 (down from ₩67.43 in FY 2022). Revenue: ₩66.2b (down 1.9% from FY 2022). Net income: ₩438.5m (down 89% from FY 2022). Profit margin: 0.7% (down from 5.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
New Risk • Feb 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₩112.9b market cap, or US$84.7m).
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩59.03 in 3Q 2022)Third quarter 2023 results: EPS: ₩44.00 (down from ₩59.03 in 3Q 2022). Revenue: ₩17.4b (up 12% from 3Q 2022). Net income: ₩2.53b (down 26% from 3Q 2022). Profit margin: 15% (down from 22% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 23Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 30% over the past three years.
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.
New Risk • Jun 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.0% net profit margin).
Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₩1,966, the stock trades at a trailing P/E ratio of 59.3x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 99% over the past three years.
Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩1,614, the stock trades at a trailing P/E ratio of 23.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 134% over the past three years.
Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩67.43 (vs ₩82.02 in FY 2021)Full year 2022 results: EPS: ₩67.43 (down from ₩82.02 in FY 2021). Revenue: ₩67.4b (down 6.9% from FY 2021). Net income: ₩4.00b (down 1.6% from FY 2021). Profit margin: 5.9% (up from 5.6% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩1,420, the stock trades at a trailing P/E ratio of 34.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 1.3% over the past three years.
Buying Opportunity • Mar 07Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be ₩2,210, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 34% per annum over the last 3 years. The company has become profitable over the last 3 years.
Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS ₩60.00 (vs ₩17.00 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩33.0b (down 16% from 3Q 2020). Net income: ₩3.01b (up 282% from 3Q 2020). Profit margin: 9.1% (up from 2.0% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 23Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₩2,665, the stock trades at a trailing P/E ratio of 30.8x. Average trailing P/E is 21x in the Chemicals industry in South Korea. Total returns to shareholders of 47% over the past three years.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩1,955, the stock trades at a trailing P/E ratio of 22.7x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 5.0% over the past three years.
Reported Earnings • May 16First quarter 2021 earnings released: EPS ₩18.00 (vs ₩3.00 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩34.0b (up 17% from 1Q 2020). Net income: ₩851.5m (up ₩969.3m from 1Q 2020). Profit margin: 2.5% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
分析記事 • Apr 14Returns At SANGBO (KOSDAQ:027580) Are On The Way UpThere are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
分析記事 • Mar 19SANGBO (KOSDAQ:027580) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
お知らせ • Feb 22SANGBO Corp., Annual General Meeting, Mar 24, 2021SANGBO Corp., Annual General Meeting, Mar 24, 2021, at 09:00 Korea Standard Time.
Is New 90 Day High Low • Feb 08New 90-day high: ₩1,530The company is up 18% from its price of ₩1,300 on 10 November 2020. The South Korean market is up 25% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.
分析記事 • Dec 09SANGBO (KOSDAQ:027580) Takes On Some Risk With Its Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Is New 90 Day High Low • Dec 01New 90-day high: ₩1,490The company is up 3.0% from its price of ₩1,445 on 02 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
Reported Earnings • Nov 13Third quarter 2020 earnings released: ₩4.17 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩15.5b (up 12% from 3Q 2019). Net loss: ₩198.9m (loss narrowed 91% from 3Q 2019). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.